Danda Chapagai

3PUBLICATIONS
3CO-AUTHORS
Molecular targetsBasic pharmacologyClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 16, 2025
Structural regulation of PLK1 activity: implications for cell cycle function and drug discovery.

Danda Chapagai, Klaus Strebhardt, Michael D Wyatt

|Jul 11, 2023
Structural Basis for Variations in Polo-like Kinase 1 Conformation and Intracellular Stability Induced by ATP-Competitive and Novel Noncompetitive Abbapolin Inhibitors.

Danda Chapagai, George Merhej, Campbell McInnes

|Jul 02, 2021
Nonpeptidic, Polo-Box Domain-Targeted Inhibitors of PLK1 Block Kinase Activity, Induce Its Degradation and Target-Resistant Cells.

Danda Chapagai, Gurusankar Ramamoorthy, Jessy Varghese

Pageof 1

Frequent Collaborators

3 joint publications

Campbell McInnes

3 joint publications

Michael D Wyatt

1 joint publications

Klaus Strebhardt